￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

Oncology

Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
Indications of Talatumumab
Indications of Talatumumab

2025-10-19 11:44:20

Talatuzumab is an innovative bispecific antibody drug developed by Amgen of the United States for the treatment of extensive-stage small cell lung cancer (ES-SCLC) that has progressed after platinum-containing chemotherapy.

Check Details
FDA approves u200c Lurbinectedin for the treatment of metastatic small cell lung cancer

2025-10-19 11:44:20

Check Details
Usage and dosage of Lurbinectedin: recommended dose, dose adjustment

2025-10-19 11:44:20

Check Details
Side effects and common adverse reactions of Lurbinectedin

2025-10-19 11:44:20

Check Details
Detailed instructions for Lurbinectedin: indications, usage and dosage, side effects and precautions

2025-10-19 11:44:20

Check Details
Chinese instructions for rubidine (Zepzelca)

2025-10-19 11:44:20

Check Details
Detailed instructions for Durvalumab: indications, usage and dosage, side effects and precautions

2025-10-19 11:44:20

Check Details
Tarlatamab FDA Approved for Treatment of Extensive Stage Small Cell Lung Cancer

2025-10-19 11:44:20

Check Details
Tarlatamab usage and dosage: recommended dosage, special populations and delayed dosing dosage adjustments

2025-10-19 11:44:20

Check Details
Side effects and common adverse reactions of Tarlatamab

2025-10-19 11:44:20

Check Details
Detailed instructions for Tarlatamab

2025-10-19 11:44:20

Check Details
Tarlatamab (Tarlatamab) Chinese instruction manual: indications, usage and dosage, adverse reactions, precautions

2025-10-19 11:44:20

Check Details
Category
相关知识